DEUTSCHE BANK AG\ - HISTOGENICS CORP ownership

HISTOGENICS CORP's ticker is HSGX and the CUSIP is 43358V109. A total of 19 filers reported holding HISTOGENICS CORP in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of HISTOGENICS CORP
ValueSharesWeighting
Q2 2018$631,000
+85.6%
252,498
+103.8%
0.00%
Q1 2018$340,000
+132.9%
123,896
+72.8%
0.00%
Q4 2017$146,000
+78.0%
71,706
+71.1%
0.00%
Q3 2017$82,000
+331.6%
41,900
+263.5%
0.00%
Q4 2016$19,000
+11.8%
11,528
+105.9%
0.00%
Q3 2016$17,000
+750.0%
5,600
+833.3%
0.00%
Q4 2015$2,0006000.00%
Other shareholders
HISTOGENICS CORP shareholders Q1 2016
NameSharesValueWeighting ↓
Sofinnova Management VIII, L.L.C. 2,077,040$3,469,0001.95%
Abingworth LLP 888,889$1,440,0001.20%
ARMISTICE CAPITAL, LLC 1,264,000$2,111,0000.50%
Third Security, LLC 2,690,570$4,493,0000.24%
Perceptive Advisors 1,777,777$2,968,0000.21%
CARL DOMINO INC 87,000$145,0000.16%
SABBY MANAGEMENT, LLC 944,891$1,578,0000.09%
Palo Alto Investors LP 302,922$506,0000.03%
PURA VIDA INVESTMENTS, LLC 13,526$23,0000.01%
Virtu KCG Holdings LLC 14,764$25,0000.00%
View complete list of HISTOGENICS CORP shareholders